Showing 411-420 of 7442 results for "".
Hyaluronic Acid as Filler and Moisturizer
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/hyaluronic-acid-as-filler-and-moisturizer/19420/Most people are common with hyaluronic acid being used as a filler to remove lines and wrinkles. However, it also serves as a great moisturizer when applied topically in the proper form. In this episode of DermTV, Dr. Schultz shares everything you need to know about hyaluronic acid.Acute Contact Urticaria Due To Use of Cocamidopropyl Betaine-Containing Products Confirmed with Patch Testing
https://practicaldermatology.com/topics/other-dermatology/acute-contact-urticaria-due-to-use-of-cocamidopropyl-betaine-containing-products-confirmed-with-patch-testing/24218/A 23-year-old Caucasian woman presented with progressive worsening recurrent symptoms of hives, burning sensation, and pruritus located on the skin of the face, neck, and arms (see Fig 1, Fig 2). These symptoms began following the use of Biolage Matrix shampoo. She started taking antihistamines (lorAlternative Therapies for the Treatment of Acne
https://practicaldermatology.com/topics/acne-rosacea/alternative-therapies-for-the-treatment-of-acne/23787/Many patients are interested in alternative options instead of or alongside prescription acne treatments.Analyzing Safety Data From Level Up
https://practicaldermatology.com/series/the-practical-dermatology-podcast/analyzing-safety-data-from-level-up/33944/The latest news and updates, plus Matthew Zirwas, MD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss the importance of the Week 16 safety data from the Level Up study on upadacitinib. Silverberg JI, Bunick CG, et al. Efficacy and safety of upadacitinib versuAdvances in the Treatment of Reticular Erythematous Mucinosis
https://practicaldermatology.com/youngmd-connect/resident-resource-center/advances-in-the-treatment-of-reticular-erythematous-mucinosis/23491/Considering nicotinamide’s anti-inflammatory properties for inflammatory dermatological conditions to avoid steroid and antibiotic overuse.Contemporary African-American Hair Care Practices
https://practicaldermatology.com/topics/practice-management/contemporary-african-american-hair-care-practices/21176/As trends and sensibilities regarding hair practices shift, it is important for physicians to understand the needs of African-American patients in order to appropriately discuss healthy hair habits.Applying White Glove Service in the Practice
https://practicaldermatology.com/topics/practice-management/applying-white-glove-service-in-the-practice/23643/Help set your practice apart with these tips for providing unparalleled customer service to your patients.It's Time to Get Serious About Scalp Psoriasis Treatment
https://practicaldermatology.com/topics/practice-management/its-time-to-get-serious-about-scalp-psoriasis-treatment/20545/Largely due to adherence issues, topical treatments don't work for many scalp psoriasis patients.Study Highlights Top-Rated Dermatology Education Apps
https://practicaldermatology.com/topics/practice-management/study-highlights-top-rated-dermatology-education-apps/23565/Researchers rated apps based on four key features.Anti-OX40 Ligand Antibody Trials
https://practicaldermatology.com/series/updates-atopic-dermatitis/anti-ox40-ligand-antibody-trials/29531/Lead study author Stephan Weidinger, MD, PhD, Director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein, discusses the phase 2b STREAM-AD trial, evaluating amlitelimab in adult patients with moderate-to-severe atopic dermatitis.